Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Glaxosmithkline Plc (GSK)

2014-07-23@21:26:52 ET
GlaxoSmithKline plcCorporate Event Announcement Notice (WSH)

2014-07-23@16:51:21 ET
SmarTrend Watching for Potential Rebound in Shares of GlaxoSmithKline After 5.98% Loss (PSM)

2014-07-23@16:50:51 ET
Watch for GlaxoSmithKline to Potentially Rebound After Falling 5.98% Yesterday (PSM)

2014-07-23@14:24:36 ET
Wednesday's ETF with Unusual Volume: PPH (MNV)

2014-07-23@14:04:14 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Support At $52.96 (FBM)

2014-07-23@14:03:55 ET
Shares of GlaxoSmithKline Are Moving Lower on 5.1x Above-Average Volume (GSK) (F82)

2014-07-23@13:34:00 ET
INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Announced by Law Offices of Howard G. Smith (BIZ)

2014-07-23@12:18:12 ET
Glaxo Leads Declines Among European ADRs on Disappointing Earnings, Outlook (MID)

2014-07-23@12:03:03 ET
Stock Investors Sell Off Shares of GlaxoSmithKline, Down 4.9% (F77)

2014-07-23@09:30:03 ET
Ligand Partner GSK Announces Record Quarterly Promacta(TM)/Revolade(TM) Revenue of $92 Million (BIZ)

2014-07-23@09:21:51 ET
Sector Update: Health-Care Shares Flat to Higher Pre-Market (MID)

2014-07-23@09:18:34 ET
Sector Update: Health Care (MID)

2014-07-23@09:03:34 ET
US Futures Point to Higher Open Amid Slew of Solid Quarterly Earnings (MID)

2014-07-23@08:44:29 ET
Shares of Valeant Pharmaceuticals International Underperformed its Peers in the Pharmaceuticals Industry (VRX, AVNR, AUXL, AGN, GSK) (F70)

2014-07-23@07:39:41 ET
GSK CEO and CFO Interviewed on Q2 2014 Results and Strategy Update (EUR)

2014-07-23@07:37:00 ET
GSK CEO and CFO Interviewed on Q2 2014 Results and Strategy Update (PRN)

2014-07-23@07:00:00 ET
(PRN)

2014-07-23@03:34:32 ET
Worldwide Market for Respiratory Devices 2014-2017 (MTO)

2014-07-23@02:18:09 ET
Lupin, US pharma firms eye GSK's mature drugs portfolio - report (MTN)

2014-07-22@11:21:19 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Resistance At $53.64 (FBM)